Cephalon (CEPH) Announces the Availability of NUVIGIL for the Treatment of Excessive Sleepiness Related To Apnea
Tweet Send to a Friend
Cephalon, Inc. (Nasdaq: CEPH) announced that NUVIGIL Tablets [C-IV], a longer-lasting formulation of modafinil, is now available. NUVIGIL ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
